Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cuernavaca
Clinical trial register · Mexico

Clinical Trials in Cuernavaca, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company12 AstraZeneca7 Boehringer Ingelheim4 Merck Sharp & Dohme LLC3 Hoffmann-La Roche3
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Cuernavaca

69 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Ciudad de Tijuana, Cuernavaca, Culiacán, Mexico City, Mérida, Veracruz, Zapopan
2026-08-14
Not yet open
Autonomous University of Morelos
Not applicable
192
Cuernavaca
2026-08-10
Recruiting
AstraZeneca
Phase 3
2,000
Cuernavaca
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Chihuahua City, Cuernavaca, Guadalajara, Mexico City, Monterrey, Zapopan
2026-07-06
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Aguascalientes, Cuernavaca, San Luis Potosí City, Culiacan Sinaloa, Distrito Federal
2026-05-11
Recruiting
Eli Lilly and Company
Phase 2
531
Ciudad de Tijuana, Cuernavaca, Guadalajara, Irapuato, Mexico City, Mérida, Tlalnepantla, Torreón
2026-05-06
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Col Saucito, Guadalajara, México, Delegacion Cuauhtemoc, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Col Saucito, Guadalajara, Delegacion Cuauhtemoc, México, Cuernavaca, San Pedro Garza García, Ciudad Madero
2026-03-16
Recruiting
Deborah Salvo
Not applicable
510
Cuernavaca
2026-02-16
Recruiting
Eli Lilly and Company
Phase 3
7,140
Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
4,500
Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Metepec, Mexico City, Mérida, Monterrey
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Actopan, Aguascalientes, Ciudad Madero, Cuernavaca, Culiacán, Guadalajara, Hermosillo, León
2025-09-02
Recruiting
Amgen
Phase 3
12,800
Guadalajara, Mexico City, Cuernavaca, Monterrey, Culiacán, Tampico, Mérida, Cuauhtémoc
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey
2025-07-22
Recruiting
Sanofi
Phase 3
2,440
Torreón, Cuernavaca, Tizimín, Chihuahua City, Ecatepec de Morelos
2025-07-11
Recruiting
GlaxoSmithKline
Phase 1/2
451
Tuxtla Gutiérrez, Cuernavaca, Mexico City, San Pedro Garza García
2025-06-11
Recruiting
AstraZeneca
Phase 3
15,100
Acapulco, Aguascalientes, Chihuahua City, Cuauhtémoc, Cuernavaca, Culiacán, Guadalajara, Mexico City
2025-06-04
Recruiting
AstraZeneca
Phase 3
990
Benito Juárez, Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Mérida, Monterrey, Morelia
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Acapulco, Aguascalientes, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara, Mexico City
2025-03-14
Active, closed
Sanofi
Phase 3
2,360
León, Mexico City, Morelia, Cuernavaca, Temixco, Ecatepec de Morelos
2025-02-18
Active, closed
argenx
Phase 3
631
Torreón, León, Guadalajara, Cuernavaca, Monterrey, Culiacán, Mérida, Chihuahua City
2025-01-15
Recruiting
Pfizer
Phase 3
2,330
León, Pachuca, Cuernavaca, Monterrey, Mexico City, Veracruz
2024-12-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
León, Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Veracruz
2024-12-02
Recruiting
UCB Biopharma SRL
Phase 3
450
Cuernavaca, Guadalajara, Mexico City
2024-11-21
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mexico City, Mérida, Veracruz, Xalapa
2024-11-12
Active, closed
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
NCT06651957Human Immunodeficiency Virus, Human Papillomavirus-Related Anal Squamous Cell Carcinoma, High-Grade Squamous Intraepithelial Lesions
University of California, San Francisco
Observational
217
Cuernavaca
2024-10-31
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mexico City, Mérida, Veracruz, Xalapa
2024-10-14
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Aguascalientes, Cuernavaca, Culiacán, Durango, Guadalajara, Mexico City, Mérida, Monterrey
2024-08-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
León, Tlajomulco de Zúñiga, Mexico City, Cuernavaca, Monterrey, San Pedro Garza García, Oaxaca City, Mérida
2024-06-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Chihuahua City, Cuautitlán Izcalli, Cuernavaca, Jalisco, Mexico City, Mérida, Monterrey
2024-05-24
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Aguascalientes, Cuernavaca, Monterrey, Veracruz
2024-05-20
Active, closed
Eli Lilly and Company
Phase 3
10,000
Actopan, Aguascalientes, Ciudad Madero, Cuauhtémoc, Ciudad de México, Cuernavaca, Durango, Guadalajara, León
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aguascalientes, Chihuahua City, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2024-03-05
Recruiting
AstraZeneca
Phase 3
5,250
Benito Juárez, Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Juriquilla, Metepec, Mexico City
2024-02-21
Active, closed
Eli Lilly and Company
Phase 3
1,250
Guadalajara, Mexico City, Cuernavaca, Monterrey, Chihuahua City, Veracruz
2024-02-21
Recruiting
Multidimensional Intervention in Mexican Schoolchildren
NCT07185789Childhood Obesity, Pediatric Obesity, Childhood Overweight
Mexican National Institute of Public Health
Not applicable
200
Cuernavaca
2023-11-07
Recruiting
Gilead Sciences
Phase 3
402
Cuernavaca, Irapuato, Mexico City, México, Oaxaca City, Veracruz
2023-09-07
Active, closed
Hoffmann-La Roche
Phase 3
459
Fracc Lomas Del Campestre, Morelia, Cuernavaca
2023-08-08
Active, closed
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NCT06002126Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion, HIV Infections
Weill Medical College of Cornell University
Not applicable
1,001
Cuernavaca
2023-08-02
Active, closed
Viatris Innovation GmbH
Phase 3
451
Cuernavaca, Guadalajara, León, Mexico City, Mérida, Monterrey, Oaxaca City, Querétaro
2023-06-26
Recruiting
Pfizer
Phase 3
318
Guadajalara, Guadalajara, Cuauhtémoc, Mexico City, Cuernavaca
2023-05-20
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
León, Actopan, Guadalajara, Gustavo Adolfo Madero, Mexico City, Tlalpan, Cuernavaca, Monterrey
2023-03-09
By invitation
Eli Lilly and Company
Phase 3
333
Chihuahua City, Zapopan, Mexico City, Cuernavaca, Monterrey, Veracruz
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Guadalajara, Cuernavaca, Monterrey, San Luis Potosí City, Culiacán, Ciudad Madero, Xalapa, Aguascalientes
2023-03-01
Active, closed
Bristol-Myers Squibb
Phase 3
513
Torreón, León, Guadajalara, Zapopan, Mexico City, Cuernavaca, Monterrey, Chihuahua City
2023-01-12
Active, closed
Eli Lilly and Company
Phase 3
377
Chihuahua City, Cuernavaca, Mexico City, Monterrey, Veracruz, Zapopan
2022-10-18
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aguascalientes, Chihuahua City, Ciudad Madero, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara
2022-10-11
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
379
Cuernavaca, Guadalajara, Mexicali, Mexico City, Mérida, México, Monterrey, Torreón
2022-09-16
Active, closed
Biogen
Phase 2/3
450
Guadalajara, Mexico City, Cuernavaca, Mérida, Aguascalientes, Chihuahua City
2022-09-13
By invitation
Biogen
Phase 3
864
Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Durango
2022-06-10
Recruiting
Pfizer
Phase 3
160
Mexico City, Cuernavaca, Monterrey, Mérida, Aguascalientes, Veracruz
2022-03-07
Active, closed
Inventiva Pharma
Phase 3
1,000
Guadalajara, Cuauhtémoc, Mexico City, Cuernavaca, Monterrey, Mérida, Metepec, Oaxaca City
2021-08-19
By invitation
UCB Biopharma SRL
Phase 3
760
Chihuahua City, Cuernavaca, Guadalajara, León, Mérida, Monterrey
2021-07-27
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Aguascalientes, Cuernavaca, Guadalajara
2021-07-15
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Tuxtla Gutiérrez, Guadalajara, Mexico City, Cuernavaca, San Juan del Río, Colonia Centro Orizaba
2021-06-24
Active, closed
Biogen
Phase 3
548
Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Durango, Veracruz
2021-05-25
Active, closed
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
NCT04255849HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection, HPV Infection
Weill Medical College of Cornell University
Phase 3
700
Cuernavaca
2021-02-23
Active, closed
AstraZeneca
Phase 3
640
Chihuahua City, Cuernavaca, Mérida, Monterrey, Veracruz
2020-10-19
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Guadalajara, Cuernavaca, Monterrey, Huixquilucan, Mexico City
2020-09-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Mexico City, Cuernavaca, Chihuahua City, Veracruz
2020-02-27
Active, closed
Sanofi
Observational
1,860
Cuernavaca, Monterrey, México, Puebla City, Tlalnepantla
2019-08-15
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Guadalajara, Mexico City, Cuernavaca, Monterrey
2019-03-28
Active, closed
AbbVie
Phase 3
1,242
Cuernavaca, Mérida, Del. Benito Juárez
2018-08-28
Recruiting
AMAG Pharmaceuticals, Inc.
Phase 3
129
Cuernavaca, Guadalajara, Mexico City
2018-08-13
Active, closed
AbbVie
Phase 3
1,336
Zapopan, Cuernavaca, Mérida, Del. Benito Juárez
2018-04-09
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Chihuahua City, Cuernavaca, Culiacán, México, Oaxaca City, Zapopan
2014-11-26
Active, closed
Eli Lilly and Company
Phase 3
493
Torreón, México, León, Guadalajara, Mexico City, Cuernavaca, Juchitán de Zaragoza, Colinas Del Cimatario
2014-11-06
Active, closed
AbbVie
Observational
8,250
León, Pachuca, Guadalajara, Cuernavaca, Monterrey, Chihuahua City, Metepec, Mexico City
2013-04-29
Recruiting
International Agency for Research on Cancer
Observational
3,000
Cuernavaca
2012-10-12
Rows per page Showing 1–69 of 69
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/cuernavaca

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 69 of those studies with a site in Cuernavaca.

How many clinical trials are recruiting in Cuernavaca?

34 of the 69 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 31 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cuernavaca), 69 studies
PhaseStudiesRecruitingShare
Phase 3572982.6%
Not applicable425.8%
Observational415.8%
Phase 2212.9%
Phase 1/2111.4%
Phase 2/3101.4%

Most active sponsors

Lead sponsors with the most studies (Cuernavaca)
Lead sponsorStudiesRecruiting
Eli Lilly and Company125
AstraZeneca76
Boehringer Ingelheim43
AbbVie30
Biogen30
Hoffmann-La Roche32
Merck Sharp & Dohme LLC32
Pfizer33
Sanofi31
Novartis Pharmaceuticals21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.